The mission is to consolidate and enhance partnerships between Université Paul Sabatier, PRES Université de Toulouse, research and health bodies (CNRS, INSERM, INRA, etc.), research networks (RTRA , RTRS), foundations (2RITC, InnaBioSanté), the three competitiveness clusters and new Toulouse campuses (Toulouse cancer Campus, Aerospace Campus), and regional authorities.
The University board appointed me to carry out this mission. As a Professor of genetics and cell biology (UFR SVT) I direct a research team at the Institute of Pharmacology and Structural Biology (UMR CNRS/UPS) made up of university staff and CNRS and INSERM researchers/ITAOS, with particular interest in the molecular mechanisms that govern the emergence of genetic variations in tumours.
For the first year of the mission the focus was on:
I was also appointed Vice-president of the cancéropôle or Toulouse Cancer Campus, university vice-president and secretary of its board. In this role I contribute to joint governance between academic and industrial partners, the Innabiosanté Foundation and regional authorities, to create what is now a genuine university campus as well as a technical campus at Langlade. The campus will host three mixed units with UPS as a partner (Technological Institute for Advanced Life Sciences - Institut Technologiques des Sciences Avancées du Vivant, University Cancer Clinic - Clinique Universitaire du Cancer, and the Cancerology Research Centre - Centre de Recherche en Cancérologie).
Le Club Eco - 30_Mar_2010 - La Dépeche
Last updated October 10, 2011